Role of the Gut Microbiota in Shaping Severity of Malaria

This research investigates the role of gut microbiota in the severity and post-discharge outcomes of pediatric Plasmodium falciparum severe malaria (SM) in African children. Drawing on stool sample analyses from two independent cohort studies, one in Uganda enrolling children aged 6 months to 4 years and one in Malawi enrolling children aged 6 months to 12 years, the study characterizes gut bacterial communities using 16S rRNA gene amplicon sequencing and whole metagenome sequencing approaches. The authors report that children with SM exhibit gut bacterial dysbiosis compared to community children, with reduced alpha diversity (Shannon index and observed species) and distinct beta diversity profiles after controlling for site, age, prior antibiotic use, and sample collection timing. A central finding across cohorts is an increased relative abundance of Enterobacteriaceae among children with SM, and notably increased Escherichia coli abundance that was identified as a predictor of post-discharge mortality. Metagenomic pathway analyses further indicate elevated metabolic functions and genes in SM-associated microbiota that support utilization of host-derived molecules, potentially favoring Enterobacteriaceae survival and growth in the altered intestinal environment of children with severe malaria.

The study places these human findings in the context of prior mechanistic and observational work in murine models and human studies, which together suggest interactions between Plasmodium infection, intestinal inflammation, barrier dysfunction, and expansion of facultative anaerobic Gram-negative pathobionts. In mice, gut microbiota have been shown to influence susceptibility to severe malaria by modulating humoral immunity to Plasmodium and by promoting expansion of Enterobacteriaceae such as E. coli and non-typhoidal Salmonella. In human autopsy and biomarker studies, Plasmodium infection has been associated with intestinal microvascular sequestration of infected erythrocytes, inflammatory infiltrates, increased intestinal permeability, and translocation of bacteria into the blood pathways that could underlie the increased risk of invasive enteric Gram-negative infections among children with malaria. The current analysis strengthens the link between gut bacterial composition and clinical complications of SM, including a specific association of Enterobacteriaceae abundance with multiple severe malaria complications.

By identifying microbial signatures and functional pathways that correlate with mortality risk after hospital discharge, the work suggests potential therapeutic or preventive opportunities. The investigators propose that interventions targeting Enterobacteriaceae expansion whether via microbiota-directed therapies, antimicrobial stewardship, or adjunctive treatments addressing intestinal inflammation and barrier integrity may have the potential to reduce post-discharge mortality in children recovering from severe malaria. Overall, this study advances understanding of how gut microbial dysbiosis associates with disease severity and adverse outcomes in pediatric severe malaria and highlights the microbiota as a plausible and actionable contributor to post-discharge risk.